← Back to Search

Multifocal Lens

Multifocal Contact Lenses for Progressive Myopia

N/A
Waitlist Available
Led By Mervyn Bloom, OD
Research Sponsored by University of the Incarnate Word
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3years
Awards & highlights

Study Summary

This trial will study whether using a specific type of soft contact lens can help slow the progression of myopia in young adults.

Eligible Conditions
  • Progressive Myopia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Contact Lenses and Myopia Progression

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Multifocal Contact LensesExperimental Treatment1 Intervention
Group II: Single Vision Contact LensesPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of the Incarnate WordLead Sponsor
17 Previous Clinical Trials
2,509 Total Patients Enrolled
Jeff RabinLead Sponsor
Mervyn Bloom, ODPrincipal InvestigatorUniversity of the Incarnate Word

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Contact Lens and Myopia Control in Optometry School Students
Jeff Rabin 2018. "Contact Lens and Myopia Control in Optometry School Students". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04334369.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top